Abstract
Biopolymers are ubiquitous in biomedical and healthcare application. Its nanocomposites have gained more attention as antimicrobials, a drug carrier, sensors, disease diagnosis, tissue engineering, wound healing, and cancer therapy. These biopolymer composites are efficient in holding, protecting and releasing bioactive drugs such as pharmaceutics, nutraceuticals, enzymes, and probiotics. Several studies revealed a polymer-based drug delivery system in cancer therapy and microbial treatments. However, this mini-review emphasized the source, extraction, and characterizations of the biopolymers and their use in the fabrication of various drug or metals based nanocomposites followed by its utilization as drug carrier or drug to treat the various diseases such as antimicrobial infections and cancer.
Keywords: Polymers, drug delivery system, antimicrobials, anticancer agents, drug carrier, biopolymers.
Current Pharmaceutical Design
Title:Antimicrobial, Anticancer Drug Carrying Properties of Biopolymers-based Nanocomposites- A Mini Review
Volume: 24 Issue: 32
Author(s): Kandasamy Saravanakumar, Davoodbasha M. Ali, Kandasamy Kathiresan and Myeong-Hyeon Wang*
Affiliation:
- Department of Medical Biotechnology, College of Biomedical Sciences, Kangwon National University, Chuncheon, Gangwon 24341,Korea
Keywords: Polymers, drug delivery system, antimicrobials, anticancer agents, drug carrier, biopolymers.
Abstract: Biopolymers are ubiquitous in biomedical and healthcare application. Its nanocomposites have gained more attention as antimicrobials, a drug carrier, sensors, disease diagnosis, tissue engineering, wound healing, and cancer therapy. These biopolymer composites are efficient in holding, protecting and releasing bioactive drugs such as pharmaceutics, nutraceuticals, enzymes, and probiotics. Several studies revealed a polymer-based drug delivery system in cancer therapy and microbial treatments. However, this mini-review emphasized the source, extraction, and characterizations of the biopolymers and their use in the fabrication of various drug or metals based nanocomposites followed by its utilization as drug carrier or drug to treat the various diseases such as antimicrobial infections and cancer.
Export Options
About this article
Cite this article as:
Saravanakumar Kandasamy, Ali M. Davoodbasha , Kathiresan Kandasamy and Wang Myeong-Hyeon*, Antimicrobial, Anticancer Drug Carrying Properties of Biopolymers-based Nanocomposites- A Mini Review, Current Pharmaceutical Design 2018; 24 (32) . https://dx.doi.org/10.2174/1381612825666181120161300
DOI https://dx.doi.org/10.2174/1381612825666181120161300 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Chemoprevention of Cancer by Isothiocyanates and Anthocyanins: Mechanisms of Action and Structure-Activity Relationship
Current Medicinal Chemistry Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development
Current Medicinal Chemistry What Does the Future Hold for Photo-Oxidizing RuII Complexes with Polyazaaromatic Ligands in Medicinal Chemistry?
Current Topics in Medicinal Chemistry Meet Our Regional Editor
Current Topics in Medicinal Chemistry Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review
Mini-Reviews in Medicinal Chemistry Breast Cancer: Understanding Sensitivity and Resistance to Chemotherapy and Targeted Therapies to Aid in Personalised Medicine
Current Cancer Drug Targets The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice
CNS & Neurological Disorders - Drug Targets Impact of Glycemic Variability and Hypoglycemia on the Mortality and Length of Hospital Stay among Elderly Patients in Brazil
Current Diabetes Reviews Proteasome Inhibitors Therapeutic Strategies for Cancer
Recent Patents on Anti-Cancer Drug Discovery Differential Cytotoxicity, Cellular Uptake, Apoptosis and Inhibition of BRCA1 Expression of BRCA1-Defective and Sporadic Breast Cancer Cells Induced by an Anticancer Ruthenium(II)-Arene Compound, RAPTA-EA1
Anti-Cancer Agents in Medicinal Chemistry Epigenetic Targeting of Platinum Resistant Testicular Cancer
Current Cancer Drug Targets COMMENTARY: Pre-emptive Nutrition: Refining the Targets of Drugs Targeted to Colorectal Cancer
Current Cancer Drug Targets Anticancer Studies of Leucovorin against Methotrexate Induced Genotoxicity in Swiss Albino Mice
Letters in Drug Design & Discovery Non-coding RNAs in Lung Cancer Chemoresistance
Current Drug Metabolism Neurological Disorders in Medical Use of <i>Cannabis</i>: An Update
CNS & Neurological Disorders - Drug Targets The Recent Electrochemical Biosensor Technologies for Monitoring of Nucleic Acid Hybridization
Current Analytical Chemistry The DNA Methylation Machinery as a Therapeutic Target
Current Drug Targets Microarray Data Integration: Frameworks and a List of Underlying Issues
Current Bioinformatics Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer
Reviews on Recent Clinical Trials Dermatological, Cardiovascular and Neurological Morphohistopathological Effects of Fluoropyrimidine-based Chemotherapy in Humans
Clinical Cancer Drugs